News About: Pharm. Industry
Kolon Life cancelled for ‘Invossa’ technology export agreement with Mitsubishi Tanabe
When it comes to the Invossa technology export, Kolon Life Science officially announced on the 27th, “Mitsubishi Tanabe Pharma filed mediation at the International Chamber of Commerce. The mediation will be proceeded ...
Chong Kun Dang acquires U.S. process patent of CKD-11101, anemia therapy biosimilar
Chong Kun Dang(CEO Young-Joo Kim) announced on the 27th that the company acquired a process patent of ‘CKD-11101,’ a second-generation biosimilar for the treatment of anemia, in the U.S.
The process patent, a patent ...
Employees at multinational pharma branches in Korea make KRW 76 million salary a year per
The average annual salary of employees working for multinational pharmaceutical companies’ branches was about KRW 76 million, and employees at GlaxoSmithKline were making the highest annual salary of KRW 131 million o...
CJ HealthCare signs co-sales agreement of Dong-A ST’s antidiabetics Suganon and Sugamet
CJ HealthCare(CEO Seok-Hee Kang & Sang-Hyun Yoon) announced the company signed a co-sales agreement of ‘Suganon Tab’ and ‘Sugamet XR Tab,’ DDP-4(Dipeptidyl Peptidase-4) antidiabetic DPP-4 inhibitors, with Dong-A ST(CE...
One third of R&D expenses were spent into clinical studies in pharma industry
Pharmaceutical companies reportedly are spending 30% of their R&D expenses into the clinical study field.
Moreover, they are also spending 13% into developing biologics which have recently brought various achievement...
42 generic drugs referencing Bukwang Pharm’s ‘Dexid Tab’ were bioequivalently tested this year
This year, 291 pharmaceutical products have been bioequivalently tested. The number was reportedly increased by 46% compared to the same time period.
This means Korean pharmaceutical companies have been very active i...
Eye drop manufacturers strongly opposing to disposable eye drop price cuts
In regards to the drug reassessment standards which will become a base to cut drug price for disposable eye drops, eye drop manufacturers have strongly opposed to the government and argues that the drug price will dro...
“It is urgent to develop new drugs to address antibiotic resistance threatening humanity”
As the antibiotic resistance issue is getting serious, the world is struggling to find a solution. Even in Korea, some organizations have started to make moves to participated in finding the solution.
When it comes t...
3 of 10 Korean pharmaceutical companies having debt ratio higher than 100%
3 of 10 Korean pharmaceutical companies were pointed out as a company with unsound financial structure with a debt ratio higher 100%.
Yakup Shinmoon(www.yakup.com) analyzed the debt ratio in 2017 audit reported that ...
Celltrion’s biosimilar ‘Truxima’ acquires approval in Australia
Celltrion announced the company acquired approval of Truxima(generic name: rituximab), an antibody biosimilar for the treatment of hematologic malignancy, from the Australian Therapeutic Goods Administration on the 20...
